145 related articles for article (PubMed ID: 11156227)
41. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes.
Ibrahim H; Mondress M; Tello A; Fan Y; Koopmeiners J; Thomas W
J Am Soc Nephrol; 2005 Apr; 16(4):1051-60. PubMed ID: 15716336
[TBL] [Abstract][Full Text] [Related]
42. Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C.
Risch L; Huber AR
Clin Chim Acta; 2005 Jun; 356(1-2):204-11. PubMed ID: 15936319
[TBL] [Abstract][Full Text] [Related]
43. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
44. Glomerular filtration rate in children with solid tumors: normative values and a new method for estimation.
Brandt JR; Wong C; Jones DR; Qualls C; McAfee N; Brewer E; Watkins SL
Pediatr Hematol Oncol; 2003 Jun; 20(4):309-18. PubMed ID: 12746163
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of two dose individualisation methods for carboplatin.
Desoize B; Dufour R; Urien S; Kaltenbach M; Colin P
Anticancer Res; 1996; 16(4A):2073-8. PubMed ID: 8712745
[TBL] [Abstract][Full Text] [Related]
46. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
[TBL] [Abstract][Full Text] [Related]
47. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.
Froissart M; Rossert J; Jacquot C; Paillard M; Houillier P
J Am Soc Nephrol; 2005 Mar; 16(3):763-73. PubMed ID: 15659562
[TBL] [Abstract][Full Text] [Related]
48. Lean body mass-adjusted Cockcroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine.
Lim WH; Lim EM; McDonald S
Nephrology (Carlton); 2006 Jun; 11(3):250-6. PubMed ID: 16756641
[TBL] [Abstract][Full Text] [Related]
49. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
50. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic study of carboplatin given on a 5-day intravenous schedule.
Ando Y; Minami H; Saka H; Ando M; Sugiura S; Sakai S; Shimokata K
Jpn J Cancer Res; 1997 May; 88(5):517-21. PubMed ID: 9247610
[TBL] [Abstract][Full Text] [Related]
52. Does cystatin C improve the precision of Cockcroft and Gault's creatinine clearance estimation?
Gabutti L; Ferrari N; Mombelli G; Marone C
J Nephrol; 2004; 17(5):673-8. PubMed ID: 15593034
[TBL] [Abstract][Full Text] [Related]
53. Estimation of the area under the concentration-versus-time curve of carboplatin following irinotecan using a limited sampling model.
Asai G; Ando Y; Saka H; Ando M; Sugiura S; Sakai S; Hasegawa Y; Shimokata K
Eur J Clin Pharmacol; 1998; 54(9-10):725-7. PubMed ID: 9923575
[TBL] [Abstract][Full Text] [Related]
54. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in Cancer Patients.
Graciano Vera N; Pino Villarreal L; Ureña Vargas J
Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
[TBL] [Abstract][Full Text] [Related]
55. [Assessment of formulas of predicted creatinine clearance from serum creatinine].
Manabe S; Orita Y; Sakata M
Rinsho Byori; 1995 Feb; 43(2):162-8. PubMed ID: 7699931
[TBL] [Abstract][Full Text] [Related]
56. The use of the Calvert formula to determine the optimal carboplatin dosage.
van Warmerdam LJ; Rodenhuis S; ten Bokkel Huinink WW; Maes RA; Beijnen JH
J Cancer Res Clin Oncol; 1995; 121(8):478-86. PubMed ID: 7642691
[TBL] [Abstract][Full Text] [Related]
57. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
Dooley MJ; Poole SG; Rischin D; Webster LK
Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
[TBL] [Abstract][Full Text] [Related]
58. New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.
Janowitz T; Williams EH; Marshall A; Ainsworth N; Thomas PB; Sammut SJ; Shepherd S; White J; Mark PB; Lynch AG; Jodrell DI; Tavaré S; Earl H
J Clin Oncol; 2017 Aug; 35(24):2798-2805. PubMed ID: 28686534
[TBL] [Abstract][Full Text] [Related]
59. Carboplatin dosage formulae can generate inaccurate predictions of Carboplatin exposure in carboplatin/paclitaxel combination regimens.
Nannan Panday VR; van Warmerdam LJ; Huizing MT; Ten Bokkel Huinink WW; Vermorken JB; Giaccone G; Veenhof CH; Schellens JH; Beijnen JH
Clin Drug Investig; 1998; 15(4):327-35. PubMed ID: 18370488
[TBL] [Abstract][Full Text] [Related]
60. Quick prediction of creatinine clearance without the necessity of urine collection.
Charleson HA; Bailey RR; Stewart A
N Z Med J; 1980 Dec; 92(673):425-6. PubMed ID: 6937780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
